%0 Journal Article
%T Dos modalidades terap¨¦uticas en el alumbramiento activo Two therapeutic modalities in the active childbirth
%A ¨¢ngel Ernesto Caveda Gil
%A Danilo N¨¢poles M¨¦ndez
%A Dayana Couto N¨²£¿ez
%J MEDISAN
%D 2011
%I Centro Provincial de Ciencias M¨¦dicas
%X Se utiliz¨® un nuevo plan terap¨¦utico para el alumbramiento activo, basado en el empleo de misoprostol por v¨ªa sublingual, con vistas a evaluar su eficacia y seguridad. Para ello se realiz¨® un ensayo cl¨ªnico pragm¨¢tico de fase III con caracter¨ªsticas espec¨ªficas, que incluy¨® a gestantes tomadas como controles y tratadas seg¨²n lo normado en ese caso, as¨ª como 2 grupos experimentales (1 y 2), en cuyas integrantes se emple¨® el proceder activo no invasivo propuesto para el estudio. La muestra qued¨® conformada por 600 pacientes atendidas en el Servicio de Partos del Hospital Ginecoobst¨¦trico "Mariana Grajales Coello" de Santiago de Cuba desde junio de 2009 hasta igual mes de 2010. En los 2 ¨²ltimos, tanto el tiempo de alumbramiento promedio como el volumen de sangrado calculado fueron menores que en el primero, de donde se concluy¨® que el misoprostol a las dosis y v¨ªa propuestas result¨® ser m¨¢s eficaz y seguro que la oxitocina. A new therapeutic plan was used for the active childbirth, based on sublingual misoprostol use, aimed at evaluating its effectiveness and safety. For this, a phase III pragmatic clinical trial was carried out with specific characteristics that included pregnant women taken as controls and treated according to the standards in that case, as well as 2 experimental groups (1 and 2) in whom the active and non invasive procedure proposed for the study was used. The sample was formed by 600 pregnant women assisted at the Childbirth Service of "Mariana Grajales Coello" Gynecological and Obstetrical Hospital in Santiago de Cuba from June, 2009 to the same month of 2010. In the 2 last groups, both the time of average childbirth and the volume of calculated bleeding were smaller than in the first one, and it was concluded that misoprostol at the doses and administration route proposed turned out to be more effective and safe than oxytocin.
%K embarazo
%K misoprostol
%K oxitocina
%K alumbramiento activo
%K hospital materno
%K pregnancy
%K misoprostol
%K oxytocin
%K active childbirth
%K maternal hospital
%U http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S1029-30192011000800001